• about axogen
    • management team
    • board of directors
    • careers
    • partners
    • esg report
    • code of ethics and conduct
    • patents
  • investors
  • news
  • contact
    • find a rep
    • international distributors
    • find referring surgeon
  • healthcare professionals
  • patients
COVID-19 Statement A letter from our CEO
Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • ESG Report
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Info
    • Contacts
    • FAQ
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

Axogen, Inc. Reports 2021 Second Quarter Financial Results

Aug 4, 2021

Axogen, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference

Jul 22, 2021

Axogen, Inc. Appoints John H. Johnson to Board of Directors

Jul 19, 2021

Axogen, Inc. to Report Second Quarter Financial Results and Host Conference Call on August 4, 2021

Jul 14, 2021

Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference

May 18, 2021

Axogen, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference

May 6, 2021

Axogen, Inc. Reports 2021 First Quarter Financial Results

May 5, 2021

Axogen, Inc. to Report First Quarter Financial ResultsĀ and Host Conference Call on May 5, 2021

Apr 14, 2021

Axogen, Inc. Promotes Peter J. Mariani to Executive Vice President and Chief Financial Officer

Mar 1, 2021

Axogen, Inc. Reports 2020 Fourth Quarter and Full-Year Financial Results

Feb 22, 2021
RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...29
    Next

    13631 Progress Blvd, Suite 400
    Alachua, FL 32615

    • contact
    • careers
    • Privacy Policy
    • Terms of Use
    • Legal Notices
    • Instagram Logo
    • Twitter Logo
    • Linkedin Logo
    • Facebook Logo

    © 2023 Axogen Corporation. The stylized "a" logo, Revolutionizing the Science of Nerve Repair and Avance Nerve Graft are trademarks of Axogen Corporation.

    Top

    You are now leaving axogeninc.com

    Axogen is not responsible for content or policies on linked sites.